This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (52)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Seizures, Nonepileptic  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Dennis L. Andress, MD; Judy Ozuna, RN, MS; David Tirschwell, MD; Lucinda Grande, BS; Meshell Johnson, MD; Arnold F. Jacobson, MD, PhD; William Spain, MD

Arch Neurol. 2002;59:781-786.

Background  Long-term antiepileptic drug (AED) therapy is a known risk factor for bone loss and fractures. Vitamin D deficiency is frequently cited as a cause for bone loss in patients who have seizures.

Objective  To determine whether men who have seizures, but who are otherwise healthy, suffer substantial bone loss in the hip while taking AEDs.

Patients and Methods  We prospectively examined femoral neck bone mineral density (BMD) by dual-energy x-ray absorptiometry in 81 consecutive men, aged between 25 and 54 years old (mean age, 45 years), who were attending an outpatient seizure clinic. Low BMD values were analyzed for known risk factors for bone loss. Dual-energy x-ray absorptiometry scans were repeated in 54 patients, 12 to 29 months later (mean, 19 months), to assess the rate of change in BMD over time.

Results  Multivariate linear regression analysis revealed that age (P<.001) and time receiving AEDs (P<.003) were the 2 important risk factors associated with low femoral neck BMD. Neither vitamin D deficiency, hypogonadism, cigarette smoking, nor excess alcohol intake were associated with low BMD after correcting for age and time on AEDs. Longitudinal analysis of femoral neck BMD revealed that only those in the youngest age group (25-44 years) showed significant declines in femoral neck BMD (1.8% annualized loss; 95% confidence interval, -3.1 to -0.9; P<.003) while receiving AED therapy. There was no evidence that a specific type of AED was more causally related to bone loss in this group although most patients were taking phenytoin sodium or carbamazepine during the longitudinal assessment.

Conclusions  Long-term AED therapy in young male patients who have seizures causes significant bone loss at the hip in the absence of vitamin D deficiency. Dual-energy x-ray absorptiometry scanning of the hip is useful in identifying patients who are particularly susceptible to rapid bone loss while taking AEDs.

From the Departments of Medicine (Drs Andress and Johnson) and Neurology (Mss Ozuna and Grande and Drs Tirschwell and Spain) and the Division of Nuclear Medicine (Dr Jacobson), Veterans Affairs Puget Sound Health Care System and the University of Washington School of Medicine, Seattle.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(5):878-880.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antiepileptic drug use and rates of hip bone loss in older men: A prospective study
Ensrud et al.
Neurology 2008;71:723-730.
ABSTRACT | FULL TEXT  

Progressive bone deficit in epilepsy
Sheth et al.
Neurology 2008;70:170-176.
ABSTRACT | FULL TEXT  

Two randomized vitamin D trials in ambulatory patients on anticonvulsants: Impact on bone
Mikati et al.
Neurology 2006;67:2005-2014.
ABSTRACT | FULL TEXT  

Advances in epilepsy
Kelso and Cock
Br Med Bull 2005;72:135-148.
ABSTRACT | FULL TEXT  

Metabolic concerns associated with antiepileptic medications
Sheth
Neurology 2004;63:S24-S29.
ABSTRACT | FULL TEXT  

Antiepileptic drug use increases rates of bone loss in older women: A prospective study
Ensrud et al.
Neurology 2004;62:2051-2057.
ABSTRACT | FULL TEXT  

More Evidence Associating AEDs with Bone Disease
JWatch Neurology 2002;2002:6-6.
FULL TEXT